Pre-close · Specialty Chemicals

Cross-Border Structuring Counsel for Specialty Chemicals Acquisitions

When the deal is specialty chemicals and the question is Cross-Border Structuring, the structure decisions in the first 30 days outlast the next five years. This is where Jason Powell works.

EV range $15M to $200M EV EBITDA $3M to $28M Audience Buy & Sell-side
The deal context

Specialty Chemicals deals in the lower middle market run a specific playbook. Cross-Border Structuring is where the structure either holds or starts to leak.

The typical specialty chemicals platform sits at $15M to $200M EV with EBITDA in the $3M to $28M range. The thesis runs on niche formulator or contract manufacturing buy-up. The IP lives in the formulator's head as often as in the company. Structure for that risk explicitly.

The moves

How Cross-Border Structuring actually gets structured.

  1. Map jurisdictional tax exposure with US and foreign counsel before the LOI.

  2. Plan repatriation mechanics if cash is generated offshore.

  3. Address CFIUS review where foreign capital is in the LP base.

  4. Structure for treaty benefits where the operating geographies allow.

  5. In specialty chemicals, layer in chemical inventory transfer filed as part of the Cross-Border Structuring workstream.

The common mistake

Treating cross-border deals like US deals with extra steps. Tax, regulatory, and timing assumptions break differently.

Jason's take
"Cross-border deals need three sets of advisors at the table from day one. Bring them."
Jason Powell · Cross-Border Structuring
Capital after close

The deal is one thing. The capital that opens up after close is another.

Most independent sponsors solve the closing capital and then run into the post-close capital problem alone. The capital markets relationships that matter at month 18 are part of this practice.

MONTH 18
Senior refi
MONTH 24
Dividend recap
MONTH 36
Growth equity
YEAR 4–5
Strategic exit
WORK WITH JASON

Bring the specialty chemicals deal. Get Cross-Border Structuring done right.

Direct counsel from a securities and M&A attorney with billions in structured transactions, the independent-sponsor-native playbook, and the capital markets network that opens up post-close.